The emergency use authorization (EUA) for a traditional herbal formula developed in Taiwan to treat COVID-19, known as Taiwan Chingguan Yihau (NRICM101), will be extended to June 2024, Health Minister Hsueh Jui-yuan (薛瑞元) said Sunday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
![Weekly COVID-19 cases in Taiwan surge 78%, extend climb: CDC]()
Weekly COVID-19 cases in Taiwan surge 78%, extend climb: CDCNearly 6,000 individuals sought medical treatment for COVID-19 last week, marking a 78 percent increase from the previous week and the fourth consecutive weekly rise in cases, the Centers for Disease Control (CDC) said Tuesday.05/07/2025 12:13 PM![COVID-19 epidemic phase to pass mid-August: CDC]()
COVID-19 epidemic phase to pass mid-August: CDCAlthough Taiwan is still in a COVID-19 epidemic phase, it is expected to pass by mid-August, said the Centers for Disease Control (CDC) at a press conference in Taipei on Tuesday.07/30/2024 08:01 PM![COVID-19, influenza outbreaks have peaked: CDC]()
COVID-19, influenza outbreaks have peaked: CDCCOVID-19 and influenza cases in Taiwan have peaked, with the epidemic phases likely to pass by mid-August, the Centers for Disease Control (CDC) said Tuesday.07/16/2024 08:45 PM
Latest
- Politics
Presidential Office bureau chief named Taiwan's new South Korea envoy
05/13/2025 05:43 PM - Business
Taiwan shares end up amid eased U.S.-China trade tensions
05/13/2025 05:21 PM - Society
High school students hang banners to protest possible mobile phone ban
05/13/2025 04:51 PM - Business
U.S. dollar closes sharply higher on Taipei forex market
05/13/2025 04:15 PM - Business
Taiwan Lottery to add NT$400 million to Dragon Boat Festival jackpots
05/13/2025 03:34 PM